TF and glioma: Despite the mainstream use of pSiNPs for drug loading, such as doxorubicin [18], we found that blank pSiNPs functionalised with transferrin to aid glioma-specific cell entry, are not cytotoxic [18], and can be effective at disrupting U87 cell migration across narrow physical confinements [10].